Search

Search results

58 results found

Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study

Publication: Journal Article

Dastjerdi, Mohammad, Khalid Al-Arfaj, Nambi Nallasamy, Pedram Hamrah, Ula Jurkunas, Roberto Pineda, Deborah Pavan-Langston, and Reza Dana. 2009. “Topical Bevacizumab in the Treatment of Corneal Neovascularization: Results of a Prospective, Open-Label, Noncomparative Study”. Arch Ophthalmol 127 (4): 381-9.

Keratoglobus in association with posterior polymorphous dystrophy

Publication: Journal Article

Harissi-Dagher, Mona, Reza Dana, and Ula Jurkunas. 2007. “Keratoglobus in Association With Posterior Polymorphous Dystrophy”. Cornea 26 (10): 1288-91.

Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy

Publication: Journal Article

Bitar, Maya, Cailing Liu, Alireza Ziaei, Yuming Chen, Thore Schmedt, and Ula Jurkunas. 2012. “Decline in DJ-1 and Decreased Nuclear Translocation of Nrf2 in Fuchs Endothelial Corneal Dystrophy”. Invest Ophthalmol Vis Sci 53 (9): 5806-13.

p53-regulated increase in oxidative-stress--induced apoptosis in Fuchs endothelial corneal dystrophy: a native tissue model

Publication: Journal Article

Azizi, Behrooz, Alireza Ziaei, Thomas Fuchsluger, Thore Schmedt, Yuming Chen, and Ula Jurkunas. 2011. “P53-Regulated Increase in Oxidative-Stress--Induced Apoptosis in Fuchs Endothelial Corneal Dystrophy: A Native Tissue Model”. Invest Ophthalmol Vis Sci 52 (13): 9291-7.

Comparative analysis of human-derived feeder layers with 3T3 fibroblasts for the ex vivo expansion of human limbal and oral epithelium

Publication: Journal Article

Sharma, Sandhya, Thomas Fuchsluger, Sajjad Ahmad, Kishore Katikireddy, Myriam Armant, Reza Dana, and Ula Jurkunas. 2012. “Comparative Analysis of Human-Derived Feeder Layers With 3T3 Fibroblasts for the Ex Vivo Expansion of Human Limbal and Oral Epithelium”. Stem Cell Rev 8 (3): 696-705.

Paper presentation of Jurkunas lab members at ARVO 2017

News: February 22, 2017

Congratulations to Viridiana Kocaba and Shivakumar Vasanth (co-first author with Takashi Miyai) for their abstracts selected for paper presentation at ARVO 2017 annual meeting in Baltimore, MD. Both presentations are scheduled for May 10, between 8:30-10:15am in room 308 (Session number: 409; title...

New Research Links Mitochondrial Dysfunction to Development of Fuchs’ Endothelial Corneal Dystrophy (FECD), a Common Cause of Corneal Swelling and Blindness

News: March 07, 2016

Findings could eventually lead to first non-surgical therapies and treatments for FECD. BOSTON -- Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs’ Endothelial...

Ula V. Jurkunas, MD

Page

Associate Professor of Ophthalmology, Harvard Medical School Co-director, Cornea Center of Excellence Associate Scientist, Schepens Eye Research Institute of Mass. Eye and Ear Research Area(s): Fuchs Endothelial Corneal Dystrophy, Limbal Stem Cells, Cornea, Ocular Regenerative Medicine Location:20...

Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage

Publication: Journal Article

Fuchsluger, Jurkunas, Kazlauskas, and Dana. 2011. “Anti-Apoptotic Gene Therapy Prolongs Survival of Corneal Endothelial Cells During Storage”. Gene Ther 18 (8): 778-87.

Increased clusterin expression in Fuchs' endothelial dystrophy

Publication: Journal Article

Jurkunas, Ula, Maya Bitar, Ian Rawe, Deshea Harris, Kathryn Colby, and Nancy Joyce. 2008. “Increased Clusterin Expression in Fuchs’ Endothelial Dystrophy”. Invest Ophthalmol Vis Sci 49 (7): 2946-55.